Cambridge Investment Research Advisors

Cambridge Investment Research Advisors’s Evolv Technologies EVLV Stock Holding History

Cambridge Investment Research Advisors’s Portfolio EVLV Stock Details EVLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$68K	Buy	+11,701	New	+$73.3K	﹤0.01%	3694

Other funds holding EVLV

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return

Greenwood Gearhart Fayetteville, Arkansas $2.15B AUM 25.78% 1-Year Est. Return

Campbell Capital Management Miami, Florida $279M AUM 49.18% 1-Year Est. Return

Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return

Steigerwald Gordon & Koch Leesburg, Virginia $1.01B AUM 15.33% 1-Year Est. Return

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return

Cambridge Investment Research Advisors's EVLV Position: Q2 2026 in Review

Cambridge Investment Research Advisors opened a new position in Evolv Technologies (EVLV) in Q2 2026: 11,701 shares worth $68K. The stake represents ﹤0.01% of the portfolio and ranks #3694 among its holdings.

48 funds tracked by Wall St. Rank hold EVLV as of Q2 2026.

Cambridge Investment Research Advisors held 11,701 shares of Evolv Technologies worth $68K as of Q2 2026.
Evolv Technologies was a new Cambridge Investment Research Advisors position in Q2 2026.
Evolv Technologies made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3694 holding.
48 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.